ABOUT US

Established in 2004, Creative Biolabs is highly specialized in advanced antibody biochemistry and engineering. With more than a decade of exploration and expansion, our current research and service capacity covers the entire new drug discovery and development pipeline, ranging from early discovery, pre-clinical evaluations, cGMP manufacturing, to clinical trials.

+ ABOUT TALENT

As an international cooperation, we have established offices all around the globe with more than 200 well-trained full-time scientists and technicians, who work closely with our customers and research partners to develop new medicines for a better, healthier world. After years of pursuit for perfection, Creative Biolabs has established our leadership in targeted immunotherapy and antibody-drug conjugate (ADC) development. We offer our customers with comprehensive one-stop-shop of all aspects in ADC research and evaluation, ranging from antigen selection, antibody production/optimization, payload-linker synthesis, ADC conjugation, to various stages of ADC characterization and pre-clinical evaluation. Furthermore, our inventory also contains an extensive list of linkers, payloads, payload-linker sets, and commonly used ADCs for quick deployment and concept validation.

+ ABOUT PLATFORM

Immunotherapy has entered a stage that is dominated by the ADC-based targeted therapy or precision medicine. With a large number of ADCs entering clinical test, it is obvious that the dawn of ADC has begun. With our integrated global resources in all aspects, our one-stop ADC development services will provide you with a platform that could exponentially speed up the process of ADC development, from ADC formulation to clinical evaluation, and ultimately promote science for the cause of a better tomorrow.





Inquiry

Top